CD4+CD25+FoxP3+ Regulatory Tregs Inhibit Fibrocyte Recruitment and Fibrosis via Suppression of FGF-9 Production in the TGF-β1 Exposed Murine Lung

    May 2014 in “ Frontiers in Pharmacology
    Xueyan Peng, Meagan W. Moore, Hong Peng, Huanxing Sun, Ye Gan, Robert J. Homer, Erica L. Herzog
    Image of study
    TLDR Special immune cells called Tregs can help prevent lung scarring by blocking a specific growth factor.
    The study explored the impact of CD4+CD25+FoxP3+ regulatory T cells (Tregs) on lung fibrosis in a murine model, finding that Tregs can reduce fibrosis and fibrocyte recruitment by suppressing the production of fibroblast growth factor-9 (FGF-9) in response to transforming growth factor-beta1 (TGF-β1). Depletion of Tregs resulted in a 21.2% increase in lung collagen and a 1.61-fold rise in CD45+Col Ial+ fibrocytes, while neutralizing FGF-9 led to a 55.3% reduction in lung fibrosis and a 57.5% decrease in fibrocytes, without affecting Treg levels. The study, which used 5 mice per group, suggests that Tregs play a protective role against lung inflammation and fibrosis, and that FGF-9 is a key mediator in this process. Further research is needed to fully understand the interactions between Tregs, macrophages, fibrocytes, and inflammation in lung diseases.
    Discuss this study in the Community →

    Cited in this study

    1 / 1 results